Michigan earns a B, ranking 22nd of 51 states in overall health. Ten million people live here, and the state resists any simple story. Its uninsured rate ranks among the best in the country. Its emergency room utilization ranks among the worst. It screens for cancer at above-average rates and loses people to depression at troubling ones. Michigan has solved some of the easier problems. It's still circling the harder ones.
The central contradiction: Michigan's 7.2% uninsured rate beats the national average by more than four points, ranking 6th best nationally. Yet more than one in four adults reports depression, a full four points above the national figure. People have insurance. They still can't find mental health care. With 273 designated mental health shortage areas across 83 counties, that gap isn't accidental. Having a card doesn't mean having an appointment.
A median household income of $63,499, worse than about 33 other states, and a smoking rate that edges above average complete the picture. Michigan isn't a health catastrophe. It's a state of persistent mid-tier performance, with pockets of genuine excellence and pockets of genuine crisis, sometimes separated by nothing more than a county line.
Start with Michigan's most-prescribed medication. Atorvastatin Calcium, a cholesterol-lowering statin, logged more than 5.2 million Medicare claims. That's not coincidence. That's a population managing the downstream effects of decades of metabolic stress. The state's obesity rate of 37.9% barely exceeds the national average of 37.5%, but "barely" compounds. Nearly two in five Michigan adults carry a weight burden that builds, year by year, into cardiovascular disease, type 2 diabetes, and joint deterioration. The statin is managing the result.
Michigan's death rate of 8,850 per 100,000 runs meaningfully below the national figure of 10,368. That's one of the state's strongest absolute numbers, and it reflects, in part, a population that's actually showing up for preventive care. Routine checkups at 79.1%, colorectal screening at 66.0%, cholesterol screening at 86.1%. These are above-average rates that translate into earlier catches and fewer crises.
Coverage is doing real work here too. The uninsured rate of 7.2% ranks 6th best nationally, a direct result of Medicaid expansion. Compare that to Texas at 20.7% and the stakes of that policy difference become concrete. Nearly three times as many Texans are uninsured. Fewer Michigan residents are waiting until a manageable condition becomes an emergency. Coverage is a necessary condition, not a sufficient one. But it's not nothing.
Income tells the harder story. At $63,499, Michigan's median household income trails the national median. Child poverty runs at 18.4%. Nearly one in five Michigan children grows up in a household stretched too thin, and that stress doesn't stay in childhood. It travels forward into adult health outcomes, chronic disease burden, and shortened lives. The statin at the top of the prescription list is, partly, the result.
Michigan's biggest departure from the national health picture isn't obesity or smoking. It's depression. At 27.5%, the state's rate runs four full points above the national average of 23.5%. That's roughly 2.8 million adults living with depression. It's the single largest gap in the state's CDC health profile, and it points to a system where mental health need has outrun mental health capacity by a wide margin.
The surrounding pattern makes it stranger. Michigan outperforms nationally on preventive care across almost every measure. Dental visits at 66.8% rank 7th best nationally. Colorectal screening at 66.0% beats the national average by more than five points. Routine checkups, cholesterol screening, mammography: all above national. People are getting their teeth cleaned and their colons screened. They're not getting adequate psychiatric treatment.
Where's the disconnect? It's in the distribution. The preventive care numbers reflect the insured population doing what it's supposed to. The depression gap reflects a mental health system that hasn't kept pace regardless of insurance status. You can have a Medicaid card and still wait six months for a psychiatrist. You can live in a shortage area with no realistic option at any price. Both are true in Michigan simultaneously.
Arthritis affects 29.6% of adults, more than two points above national. COPD runs at 8.6%, nearly a point above average, reflecting decades of industrial-era smoking habits. Cancer rates come in a point above national at 9.0%. On the other side: only 12.2% of Michigan adults over 65 have lost all their teeth, nearly four points better than the national figure of 16.0%. For a Rust Belt state, that's a number that surprises. The nights are easier too. Short sleep affects 34.0% of adults versus 36.7% nationally. Small comfort, but it's something.
Michigan's health struggles don't start in hospitals. They start in neighborhoods where the grocery store closed fifteen years ago and the nearest full-service supermarket is eleven miles away, in houses where the furnace needs replacing but there's no savings account, in school districts where the funding formula hasn't worked since the factories did.
Food insecurity affects 15.1% of adults, slightly better than the national 16.8%. But 14.5% of adults receive food stamps, a point above the national average. The safety net is doing work the economy itself isn't doing. One in seven Michigan adults depends on federal food assistance to eat. That number doesn't feel abstract in Flint, or in the Upper Peninsula's rural townships, where the nearest food bank can be an hour's drive.
Housing insecurity runs at 11.5%, better than the national average of 13.2%, but more than one in ten adults still reports instability in a given year. In Detroit, in Pontiac, in the industrial towns of the Thumb region, the consequences are direct: lead exposure in aging housing stock, mold, cold winters in poorly insulated homes. These aren't soft problems. They're the conditions that produce chronic disease.
Loneliness affects 32.5% of Michigan adults. Social isolation isn't a soft metric. It's a documented cardiovascular risk factor, a mental health accelerant, and a mortality predictor with effects comparable to long-term smoking. Nearly one in four adults reports inadequate emotional support. In a state already carrying a 27.5% depression rate, that compounds in ways the numbers can't fully capture.
Michigan's income inequality ratio of 4.22 means the distance between the top and bottom of the income ladder is real, persistent, and measured in years of life. A high school graduation rate of roughly 81.8% reflects a workforce pipeline that leaves too many behind before they're old enough to vote. Education shapes employment shapes income shapes health. The chain holds in both directions.
Michigan has 179,060 licensed providers across 111 specialties. Of those, 57,077 are enrolled in Medicare, and 53,637, about 94% of that group, actively accept Medicare patients. That acceptance rate is high, and it shows in the state's low opt-out numbers. Telehealth accounts for 8,919 of CMS-enrolled clinicians, roughly 16% of that group. For a state whose geography includes the remote Upper Peninsula and vast rural stretches between county seats, that share matters.
The facility infrastructure looks substantial: 148 hospitals, 423 nursing homes, 222 dialysis centers, 383 home health agencies, 164 hospice programs. The dialysis numbers, in particular, reflect a population managing end-stage renal disease, a condition closely linked to the diabetes and hypertension burden visible throughout the drug data.
But the shortage maps tell a different story about where those resources actually are. 603 primary care shortage areas carry a combined underserved population designation of 45 million, a figure that accumulates across overlapping federal shortage designations rather than counting individuals, but still indicating the scale of primary care gaps in rural and low-income urban communities. Mental health shortage areas total 273. Dental shortage areas number 258. The high dental visit rate reflects the insured population doing well. The shortage maps reflect everyone else.
The mental health workforce looks substantial on paper: 26,315 clinical social workers, 11,549 mental health counselors, 6,687 clinical psychologists. Against a depression rate of 27.5% and 273 shortage areas, it isn't close to enough. So where are the providers? In the same urban and suburban corridors where the insured patients already cluster. The shortage areas are somewhere else.
Michigan's emergency room utilization is one of its sharpest data contradictions. At 708.5 ER visits per 1,000 Medicare beneficiaries, the state is worse than about 42 others, ranking among the bottom ten nationally. Compare that to Arizona at 533.9 per 1,000. Arizona ranks 50th overall in health. Its Medicare beneficiaries still reach for the emergency room substantially less often than Michigan's do. If ER utilization were simply about poverty or poor coverage, that comparison shouldn't exist.
High ER utilization in a state with a low uninsured rate demands explanation. It isn't simply that people can't afford primary care. Michigan's coverage rates are among the nation's best. The more likely answer lives in the shortage maps: 603 primary care shortage areas mean that patients with insurance often can't find an appointment within a reasonable distance or timeframe, and end up in the ER by default. It also reflects the concentration of low-income populations in cities like Detroit and Flint, where community health infrastructure has been under strain for decades. The ER becomes the safety net when the actual safety net has gaps in it.
One thing the ER data isn't: a readmission story. Michigan's readmission figure of 20.0% rounds heavily at this level of aggregation and shouldn't be read as a precise measure. The real signal here is utilization, not rehospitalization.
One number in Michigan's drug spending demands attention before anything else. Apixaban, a blood thinner prescribed to patients with atrial fibrillation to prevent strokes and clots, generated $2.2 billion in drug costs on 2.2 million claims. That's roughly 10% of Michigan's entire Medicare drug budget from a single medication. It reflects both the prevalence of cardiovascular disease and the steep price of newer anticoagulants: drugs that work, that doctors trust, and that the system can barely afford.
The rest of the top-prescribed drugs are a portrait of chronic disease management. Atorvastatin Calcium leads by claims at 5.2 million, prescribed to lower cholesterol. Amlodipine Besylate follows at 3.2 million for blood pressure. Levothyroxine Sodium at 3.0 million for thyroid disorders. Lisinopril at 2.8 million and Metoprolol Succinate at 2.8 million, a beta-blocker for arrhythmia and hypertension. Five medications keeping a population alive despite the underlying conditions that made them necessary. Total Medicare drug spending: $21.4 billion across 99.3 million claims.
Michigan's median household income of $63,499 trails the national median, ranking worse than about 33 other states. That gap matters at the margins, where families decide between refilling a prescription and paying a utility bill. The uninsured rate of 7.2% is a genuine counterweight, reflecting decades of Medicaid policy that prioritized coverage even as wages stagnated.
Insurance network depth matters for access as much as coverage rates do. BCBS Michigan leads with 80,166 enrolled physicians, a dominance rooted in the auto industry union contracts that built the state's employer-sponsored market. Medicare follows at 57,077, then UMR at 41,790 and UnitedHealthcare at 39,535. The network breadth is real. It concentrates in the same urban and suburban corridors where providers already cluster.
Michigan's pharmaceutical industry distributed $58.9 million to 33,072 physicians across 858 companies in the most recent reporting period. That's 441,618 individual transactions averaging $133 each, the texture of routine industry engagement rather than isolated corruption, though the distinction between education and marketing is one the industry draws for itself.
Speaking and faculty fees topped the list at $16.1 million across 6,710 payments. These are Michigan physicians standing at conference podiums and dinner program lecterns, presenting branded drugs to other physicians. Paid advocates. The financial relationship with the sponsoring company is rarely disclosed to the patients those presentations ultimately influence. Consulting fees followed at $13.0 million. Food and beverage totaled $11.8 million across 405,264 transactions. Lunch by lunch, the daily texture of pharmaceutical marketing. Travel and lodging consumed $6.1 million more.
The speaking fees carry particular weight in Michigan. In a state where nearly 2.8 million adults live with depression and antidepressant prescribing shapes treatment for a substantial share of them, who speaks, for whom, and for how much is not a trivial question. Sixteen million dollars buys a lot of podium time.
Michigan has 181 active excluded providers, clinicians currently barred from Medicare, Medicaid, and other federal health programs for fraud, abuse, or other violations. That ranks worse than 44 other states. The District of Columbia, ranked 25th overall, has just 4 active exclusions. The gap between Michigan's overall ranking and its exclusion count is one of the largest in the country: 23 positions worse than its overall health performance would predict.
Active exclusions are different from historical counts. The 181 currently barred practitioners represent an ongoing accountability gap in a state with a large and growing Medicare population. Whether this reflects more aggressive enforcement, a more significant underlying fraud problem, or both, the number stands out and doesn't have a clean explanation.
Medicare opt-outs tell the other side of the same story. Only 4.2 per 1,000 providers have formally opted out of Medicare, ranking Michigan 5th best nationally. Compared to the District of Columbia's 20.1 per 1,000, Michigan's physicians are deeply committed to participating in the federal program. Most providers are choosing to stay in the system. A disproportionate number are also being removed from it for cause.
Both things are true simultaneously. It isn't a system in wholesale retreat from Medicare. It's a system with high participation rates and uneven accountability. The 181 active exclusions in a state of Michigan's overall standing deserve more scrutiny than they've received.
Michigan punches significantly above its weight in medical research. The state hosts 19,413 active clinical trials, ranking 11th nationally, well ahead of states with similar overall health rankings. NIH funding reaches $165.9 million across 361 grants, also 11th. The gravitational pull comes from major academic medical centers: the University of Michigan Health System in Ann Arbor, Henry Ford Health in Detroit, Michigan State University's programs in Lansing and Grand Rapids.
That infrastructure is real. It generates clinical trial pipelines, specialty care ecosystems, and workforce training that radiates outward into the broader region. It also offers something concrete to Michigan patients: access to experimental treatments for cancer, cardiovascular disease, and mental health conditions that track closely with the state's disease burden.
But research infrastructure doesn't automatically become community health outcomes. The distance between Ann Arbor's research output and Genesee County's death rate makes that point starkly. Whether the trials running in Washtenaw County reach the patients in Wayne County who need them most is a genuinely open question. Research that stays in Ann Arbor helps Ann Arbor. Wayne County is forty miles away. On health outcomes, it might as well be a different state.
Michigan's internal health gap runs 2.6-fold from best county to worst. The best counties cluster near Ann Arbor and in the affluent western suburbs and lakeshore communities. The worst are split between the isolated Upper Peninsula and the industrial urban counties of southeast Michigan, communities separated by geography but united by the same downstream effects of poverty, limited access, and decades of disinvestment.
Ottawa County leads the state with a death rate of 5,206 per 100,000 and median household income of $81,772. Clinton County follows at 5,260, and Livingston County at 5,584 carries the state's highest median income at $103,737. Leelanau County, a cherry-growing and wine-country peninsula on Lake Michigan, registers a death rate of 5,741 with median income of $91,727. Washtenaw County, Ann Arbor and its research hospitals, logs a death rate of 5,792 and median income of $84,704. These counties look less like Michigan and more like Massachusetts on health metrics.
Ontonagon County, at the remote western tip of the Upper Peninsula, carries a death rate of 13,371 per 100,000. That's more than twice Ottawa County's rate, a figure that places it among the most distressed communities in the country. Roscommon County comes in at 12,763. Wayne County, home to Detroit and 1.7 million people, sits at 12,684 with median income of $57,418. Oscoda County registers 12,362. Genesee County, where Flint sits, records 12,112 against median income of $60,192.
Ontonagon has about 5,600 residents. Genesee has 400,000. The scale is incomparable. The death rates aren't.
The thing Michigan can't explain away is the depression rate. When more than one in four adults is living with depression, in a state with decent insurance coverage, solid prevention rates, and a world-class research university, the implication is uncomfortable. Coverage isn't care. Enrollment isn't treatment. You can have a Medicaid card and still wait six months for a psychiatrist who accepts your plan, if you can find one within fifty miles. Michigan's 273 mental health shortage areas aren't a federal designation. They're the accumulated result of a system that built infrastructure where it was profitable and left everywhere else to manage.
The excluded provider count tells a related story. A state that ranks 22nd overall but 45th on active exclusions isn't just an outlier statistic. It's a signal that accountability mechanisms aren't keeping pace with the system's complexity. Most providers are committed to working within Medicare. The opt-out rate is among the nation's lowest. A disproportionate number of providers are also failing the people they serve. Both things are true, and the gap between them deserves more scrutiny than it's gotten.
Michigan has the pieces. It has 19,413 clinical trials running, $165.9 million in NIH grants, and an insurance infrastructure that covers more people than most states manage. What it hasn't solved is distribution: getting research to the patients, mental health providers to the shortage areas, accountability mechanisms to the practitioners who've earned them. The distance between Washtenaw County's death rate and Genesee County's isn't a failure of knowledge. Michigan knows how to build good health outcomes. It hasn't decided to build them everywhere yet.